159 related articles for article (PubMed ID: 23828141)
1. Vascular endothelial growth factor levels in bile distinguishes pancreatic cancer from other etiologies of biliary stricture: a pilot study.
Navaneethan U; Gutierrez NG; Jegadeesan R; Venkatesh PG; Poptic E; Liu X; Sanaka MR; Jang S; Vargo JJ; Parsi MA
Dig Dis Sci; 2013 Oct; 58(10):2986-92. PubMed ID: 23828141
[TBL] [Abstract][Full Text] [Related]
2. Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis.
Alvaro D; Macarri G; Mancino MG; Marzioni M; Bragazzi M; Onori P; Corradini SG; Invernizzi P; Franchitto A; Attili AF; Gaudio E; Benedetti A
Ann Intern Med; 2007 Oct; 147(7):451-9. PubMed ID: 17909206
[TBL] [Abstract][Full Text] [Related]
3. Volatile Organic Compounds in Urine for Noninvasive Diagnosis of Malignant Biliary Strictures: A Pilot Study.
Navaneethan U; Parsi MA; Lourdusamy D; Grove D; Sanaka MR; Hammel JP; Vargo JJ; Dweik RA
Dig Dis Sci; 2015 Jul; 60(7):2150-7. PubMed ID: 25708900
[TBL] [Abstract][Full Text] [Related]
4. Differences in phosphatidylcholine and bile acids in bile from Egyptian and UK patients with and without cholangiocarcinoma.
Hashim Abdalla MS; Taylor-Robinson SD; Sharif AW; Williams HR; Crossey MM; Badra GA; Thillainayagam AV; Bansi DS; Thomas HC; Waked IA; Khan SA
HPB (Oxford); 2011 Jun; 13(6):385-90. PubMed ID: 21609370
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of pancreatobiliary cancer from benign biliary strictures using neutrophil gelatinase-associated lipocalin.
Budzynska A; Nowakowska-Dulawa E; Marek T; Boldys H; Nowak A; Hartleb M
J Physiol Pharmacol; 2013 Feb; 64(1):109-14. PubMed ID: 23568978
[TBL] [Abstract][Full Text] [Related]
6. Lipidomic profiling of bile in distinguishing benign from malignant biliary strictures: a single-blinded pilot study.
Navaneethan U; Gutierrez NG; Venkatesh PG; Jegadeesan R; Zhang R; Jang S; Sanaka MR; Vargo JJ; Parsi MA; Feldstein AE; Stevens T
Am J Gastroenterol; 2014 Jun; 109(6):895-902. PubMed ID: 24710507
[TBL] [Abstract][Full Text] [Related]
7. IgG4 Levels in Bile for Distinguishing IgG4-Associated Cholangiopathy from Other Biliary Disorders: A Single Blinded Pilot Study.
Navaneethan U; Gutierrez NG; Jegadeesan R; Venkatesh PG; Poptic E; Sanaka MR; Vargo JJ; Parsi MA
Clin Endosc; 2014 Nov; 47(6):555-9. PubMed ID: 25505722
[TBL] [Abstract][Full Text] [Related]
8. Analysis of U2 small nuclear RNA fragments in the bile differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders.
Baraniskin A; Nöpel-Dünnebacke S; Schumacher B; Gerges C; Bracht T; Sitek B; Meyer HE; Gerken G; Dechene A; Schlaak JF; Schroers R; Pox C; Schmiegel W; Hahn SA
Dig Dis Sci; 2014 Jul; 59(7):1436-41. PubMed ID: 24482036
[TBL] [Abstract][Full Text] [Related]
9. Volatile organic compounds in bile can diagnose malignant biliary strictures in the setting of pancreatic cancer: a preliminary observation.
Navaneethan U; Parsi MA; Gutierrez NG; Bhatt A; Venkatesh PG; Lourdusamy D; Grove D; Hammel JP; Jang S; Sanaka MR; Stevens T; Vargo JJ; Dweik RA
Gastrointest Endosc; 2014 Dec; 80(6):1038-45. PubMed ID: 24929484
[TBL] [Abstract][Full Text] [Related]
10. Transpapillary biliary biopsy for malignant biliary strictures: comparison between cholangiocarcinoma and pancreatic cancer.
Chen WM; Wei KL; Chen YS; Chang PJ; Tung SY; Chang TS; Huang HC; Shen CH; Hsieh YY; Wu CS
World J Surg Oncol; 2016 May; 14():140. PubMed ID: 27142076
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic cytology in biliary strictures. Personal experience.
Geraci G; Pisello F; Arnone E; Modica G; Sciumè C
G Chir; 2008 Oct; 29(10):403-6. PubMed ID: 18947461
[TBL] [Abstract][Full Text] [Related]
12. Volatile organic compounds in bile for early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis: a pilot study.
Navaneethan U; Parsi MA; Lourdusamy V; Bhatt A; Gutierrez NG; Grove D; Sanaka MR; Hammel JP; Stevens T; Vargo JJ; Dweik RA
Gastrointest Endosc; 2015 Apr; 81(4):943-9.e1. PubMed ID: 25500329
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP.
Park MS; Kim TK; Kim KW; Park SW; Lee JK; Kim JS; Lee JH; Kim KA; Kim AY; Kim PN; Lee MG; Ha HK
Radiology; 2004 Oct; 233(1):234-40. PubMed ID: 15333766
[TBL] [Abstract][Full Text] [Related]
14. Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis.
Li L; Masica D; Ishida M; Tomuleasa C; Umegaki S; Kalloo AN; Georgiades C; Singh VK; Khashab M; Amateau S; Li Z; Okolo P; Lennon AM; Saxena P; Geschwind JF; Schlachter T; Hong K; Pawlik TM; Canto M; Law J; Sharaiha R; Weiss CR; Thuluvath P; Goggins M; Shin EJ; Peng H; Kumbhari V; Hutfless S; Zhou L; Mezey E; Meltzer SJ; Karchin R; Selaru FM
Hepatology; 2014 Sep; 60(3):896-907. PubMed ID: 24497320
[TBL] [Abstract][Full Text] [Related]
15. Impact of trimodality sampling on detection of malignant biliary strictures compared with patients with primary sclerosing cholangitis.
Baroud S; Sahakian AJ; Sawas T; Storm AC; Martin JA; Abu Dayyeh BK; Topazian MD; Levy MJ; Roberts LR; Gores GJ; Petersen BT; Chandrasekhara V
Gastrointest Endosc; 2022 May; 95(5):884-892. PubMed ID: 34871554
[TBL] [Abstract][Full Text] [Related]
16. Monocentric study of bile aspiration associated with biliary brushing performed during endoscopic retrograde cholangiopancreatography in 239 patients with symptomatic biliary stricture.
Fior-Gozlan M; Giovannini D; Rabeyrin M; Mc Leer-Florin A; Laverrière MH; Bichard P
Cancer Cytopathol; 2016 May; 124(5):330-9. PubMed ID: 26700399
[TBL] [Abstract][Full Text] [Related]
17. Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Malignant and Benign Biliary Obstructions.
Abdel-Razik A; ElMahdy Y; Hanafy EE; Elhelaly R; Elzehery R; M Tawfik A; Eldars W
Am J Med Sci; 2016 Mar; 351(3):259-64. PubMed ID: 26992254
[TBL] [Abstract][Full Text] [Related]
18. Measurement of IgG4 in bile: a new approach for the diagnosis of IgG4-associated cholangiopathy.
Vosskuhl K; Negm AA; Framke T; Weismüller T; Manns MP; Wedemeyer H; Plentz RR; Wedemeyer J; Lankisch TO
Endoscopy; 2012 Jan; 44(1):48-52. PubMed ID: 22198775
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of pyruvate kinase M2 in bile, serum carbohydrate antigen 19-9, and biliary brushings in diagnosing malignant biliary strictures.
Navaneethan U; Lourdusamy V; Poptic E; Hammel JP; Sanaka MR; Parsi MA
Dig Dis Sci; 2015 Apr; 60(4):903-9. PubMed ID: 25344422
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness for Diagnosis of Malignancy of Bile Pyruvate Kinase M2 in Patients with Indeterminate Biliary Stricture.
Aguilar Olivos NE; Oria-Hernández J; Briones NS; Téllez Ávila FI
Surg Laparosc Endosc Percutan Tech; 2023 Apr; 33(2):147-151. PubMed ID: 36977323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
